First Tracks Biotherapeutics, Inc.: quarterly results

TRAXNASDAQHealthcare · Pharmaceutical PreparationsNew listingsince Apr 1, 2026

Price

$41.64

November 20, 2026Market cap $1.7B

Results, quarter by quarter

When the company put out each quarter's results (its 8-K, item 2.02), what they showed against the same quarter a year before, and how the stock moved on the first session after.

Nov 3, 2026 last results

The first session after results

±5.8%average move, either way

1 times upof the last 32 times down

Largest: -6.9% on May 15, 2026 (May 14, 2026).

How the stock moved after each release

The close of the first session after the results against the close before them.

TRAX that sessionS&P 500 the same day

Every release

Revenue and diluted EPS of the quarter reported, with the change against the same quarter a year before.

  • –
    Stock, next session+5.8%
  • –
    Stock, next session-4.6%
  • –
    Stock, next session-6.9%

Times are the SEC's acceptance of the 8-K, in New York time: before 16:00 the market traded on it that day, after it the next day. A move on a results day has other causes too, and says nothing about the next one. A dash in a quarter's figures: the SEC's structured data does not have them.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.